IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4415-4421

  Zhou, Yan ^a   Sonobe, Yoshifumi ^a   Akahori, Tomohiko ^a   Jin, Shijie ^a   Kawanokuchi, Jun ^a   Noda, Mariko ^a   Iwakura, Yoichiro ^b   Mizuno, Tetsuya ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; CXCL2 CHEMOKINE; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; INTERLEUKIN 9; INTERLEUKIN 9 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH17 CELL;

AMINO ACID SEQUENCE; ANIMALS; ASTROCYTES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MIGRATION INHIBITION; CELLS, CULTURED; CHEMOKINE CCL20; CHEMOTAXIS, LEUKOCYTE; CULTURE MEDIA, CONDITIONED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-4; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; SPINAL CORD; TH17 CELLS;

EID: 79955007180     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003307     Document Type: Article

References (45)

1. Demoulin, J. B., C. Uyttenhove, E. Van Roost, B. DeLestré, D. Donckers, J. Van Snick, and J. C. Renauld. 1996. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell. Biol. 16: 4710-4716. (Pubitemid 26272124)
2. + T cells and implications for autoimmunity. J. Neuroimmune Pharmacol. 5: 198-209.
3. Knoops, L., J. Louahed, J. Van Snick, and J. C. Renauld. 2005. IL-9 promotes but is not necessary for systemic anaphylaxis. J. Immunol. 175: 335-341. (Pubitemid 40884336)
4. Soussi-Gounni, A., M. Kontolemos, and Q. Hamid. 2001. Role of IL-9 in the pathophysiology of allergic diseases. J. Allergy Clin. Immunol. 107: 575-582. (Pubitemid 32397739)
5. Kung, T. T., B. Luo, Y. Crawley, C. G. Garlisi, K. Devito, M. Minnicozzi, R. W. Egan, W. Kreutner, and R. W. Chapman. 2001. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 25: 600-605. (Pubitemid 33087111)
6. Temann, U. A., P. Ray, and R. A. Flavell. 2002. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109: 29-39. (Pubitemid 34052539)
7. Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13: 1173-1175. (Pubitemid 47530640)
8. + T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J. Exp. Med. 213: 329-339.
9. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
10. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541. (Pubitemid 351962016)
11. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nat. Med. 14: 337-342. (Pubitemid 351347910)
12. Angkasekwinai, P., S. H. Chang, M. Thapa, H. Watarai, and C. Dong. 2010. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11: 250-256.
13. + Foxp32 effector T cells. Nat. Immunol. 9: 1347-1355.
14. + natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 12885-12890.
15. Nowak, E. C., C. T. Weaver, H. Turner, S. Begum-Haque, B. Becher, B. Schreiner, A. J. Coyle, L. H. Kasper, and R. J. Noelle. 2009. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 206: 1653-1660.
16. + T cells. Eur. J. Immunol. 40: 2230-2235.
17. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factor-β "reprograms" the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
18. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
19. Li, H., B. Nourbakhsh, B. Ciric, G. X. Zhang, and A. Rostami. 2010. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J. Immunol. 185: 4095-4100.
20. Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Köhler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245-248. (Pubitemid 23093629)
21. Sonobe, Y., H. Takeuchi, K. Kataoka, H. Li, S. Jin, M. Mimuro, Y. Hashizume, Y. Sano, T. Kanda, T. Mizuno, and A. Suzumura. 2009. Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cε-dependent manner. J. Biol. Chem. 284: 31834-31842.
22. Wang, J., H. Takeuchi, Y. Sonobe, S. Jin, T. Mizuno, S. Miyakawa, M. Fujiwara, Y. Nakamura, T. Kato, H. Muramatsu, et al. 2008. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc. Natl. Acad. Sci. USA 105: 3915-3920. (Pubitemid 351723499)
23. Liang, J., H. Takeuchi, Y. Doi, J. Kawanokuchi, Y. Sonobe, S. Jin, I. Yawata, H. Li, S. Yasuoka, T. Mizuno, and A. Suzumura. 2008. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity. Brain Res. 1210: 11-19.
24. Doi, Y., T. Mizuno, Y. Maki, S. Jin, H. Mizoguchi, M. Ikeyama, M. Doi, M. Michikawa, H. Takeuchi, and A. Suzumura. 2009. Microglia activated with the Toll-like receptor 9 ligand CpG attenuate oligomeric amyloid β neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am. J. Pathol. 175: 2121-2132.
25. Mizuno, T., G. Zhang, H. Takeuchi, J. Kawanokuchi, J. Wang, Y. Sonobe, S. Jin, N. Takada, Y. Komatsu, and A. Suzumura. 2008. Interferon-g directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-g receptor and AMPA GluR1 receptor. FASEB J. 22: 1797-1806. (Pubitemid 351811457)
26. Dong, Q., J. Louahed, A. Vink, C. D. Sullivan, C. J. Messler, Y. Zhou, A. Haczku, F. Huaux, M. Arras, K. J. Holroyd, et al. 1999. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur. J. Immunol. 29: 2130-2139. (Pubitemid 29313087)
27. Kohler, R. E., A. C. Caon, D. O. Willenborg, I. Clark-Lewis, and S. R. McColl. 2003. A role for macrophage inflammatory protein-3α/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 170: 6298-6306. (Pubitemid 36682616)
28. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204: 2803-2812. (Pubitemid 350179551)
29. Beriou, G., E. M. Bradshaw, E. Lozano, C. M. Costantino, W. D. Hastings, T. Orban, W. Elyaman, S. J. Khoury, V. K. Kuchroo, C. Baecher-Allan, and D. A. Hafler. 2010. TGF-β induces IL-9 production from human Th17 cells. J. Immunol. 185: 46-54.
30. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
31. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
32. Angkasekwinai, P., H. Park, Y. H. Wang, Y. H. Wang, S. H. Chang, D. B. Corry, Y. J. Liu, Z. Zhu, and C. Dong. 2007. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204: 1509-1517. (Pubitemid 47048018)
33. Fort, M. M., J. Cheung, D. Yen, J. Li, S. M. Zurawski, S. Lo, S. Menon, T. Clifford, B. Hunte, R. Lesley, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985-995. (Pubitemid 34075378)
34. Nakata, Y., K. Matsuda, A. Uzawa, M. Nomura, M. Akashi, and G. Suzuki. 1995. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo. J. Immunol. 155: 4231-4235.
35. Schmitt, E., H. U. Beuscher, C. Huels, P. Monteyne, R. van Brandwijk, J. van Snick, and E. Ruede. 1991. IL-1 serves as a secondary signal for IL-9 expression. J. Immunol. 147: 3848-3854.
36. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240. (Pubitemid 40189432)
37. H-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397. (Pubitemid 350138974)
38. Chao, C. C., T. W. Molitor, and S. Hu. 1993. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151: 1473-1481. (Pubitemid 23219285)
39. O'Keefe, G. M., V. T. Nguyen, and E. N. Benveniste. 1999. Class II transactivator and class II MHC gene expression in microglia: Modulation by the cytokines TGF-β, IL-4, IL-13 and IL-10. Eur. J. Immunol. 29: 1275-1285. (Pubitemid 29164174)
40. Suzumura, A., M. Sawada, Y. Itoh, and T. Marunouchi. 1994. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J. Neuroimmunol. 53: 209-218. (Pubitemid 24272012)
41. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161: 3299-3306.
42. Fontaine, R. H., O. Cases, V. Lelièvre, B. Mesplès, J. C. Renauld, G. Loron, V. Degos, P. Dournaud, O. Baud, and P. Gressens. 2008. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ. 15: 1542-1552.
43. Ambrosini, E., S. Columba-Cabezas, B. Serafini, A. Muscella, and F. Aloisi. 2003. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3a/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41: 290-300. (Pubitemid 36258473)
44. Serafini, B., S. Columba-Cabezas, F. Di Rosa, and F. Aloisi. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157: 1991-2002.
45. Tanaka, Y., T. Imai, M. Baba, I. Ishikawa, M. Uehira, H. Nomiyama, and O. Yoshie. 1999. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29: 633-642. (Pubitemid 29078525)